Alex Kentsis, MD, PhD

About Me

I am a pediatric oncologist who treats children and young adults with leukemias and refractory solid tumors.

In particular, I am interested in developing treatments that maximize the success of currently available therapies and devising new therapies that are precise, curative, and safe.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

My research takes advantage of modern technologies to improve our understanding of the biologic causes of blood and solid tumors. Together with colleagues, I have made discoveries about new therapeutic targets in cancer cells, mechanisms by which cancer cells can evade new treatments, and improved strategies to overcome treatment resistance, leading to new clinical trials for patients. This work has been recognized by the Scholar Award from the American Society of Hematology, Clinical Investigator Award from the Damon Runyon Cancer Research Foundation, Young Investigator Award from the Society for Pediatric Research, and the St. Baldrick’s Arceci Innovation Award.

  • Clinical Expertise: Leukemias and Refractory Tumors in Children and Young Adults
  • Languages Spoken: English; Russian
  • Education: MD, Mount Sinai School of Medicine
  • Residencies: Medicine - Boston Children's Hospital
  • Fellowships: Pediatric Hematology/Oncology - Boston Children's Hospital; Pediatric Oncology - Dana Farber Cancer Institute
  • Board Certifications: Pediatrics; Pediatric Hematology/Oncology

My Research

Microscope iconAn icon showing a microscope. View my lab Arrow rightAn icon showing an arrow pointing to the right.

See Alex Kentsis’ laboratory
research at Memorial Sloan Kettering.

See My Colleagues


Visit PubMed for a full listing of Alex Kentsis’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.